New: Biosimilars strategies introduced.
Close
Valuable and timely information on drug therapy issues impacting today's health care and pharmacy environment.
January 9, 2024 - Lupin launched an AB-rated generic version of Bausch Health’s Prolensa (bromfenac) ophthalmic 0.07% solution.
Download PDF
Return to publications
